Cancer Immunotherapy Market
                     Cancer Immunotherapy Market
Set to Exceed USD 117.82 billion by 2026 | CAGR 9.3%
“Cancer Immunotherapy Market Share, Size, Trends, 
Industry Analysis Report By Type (Monoclonal 
Antibodies, Cancer Vaccines, Check Point Inhibitors & 
Immunomodulators); By Application (Lung Cancer, 
Breast Cancer, Colorectal Cancer, Melanoma, Prostate 
Cancer, Head & Neck Cancer); By End-user (Hospital, 
Clinics, Others); By Regions, Segments & Forecast, 
2020 - 2026”
Cancer Immunotherapy Market Estimate & Forecast to 2026
The global cancer immunotherapy market size is expected to reach USD 117.82 billion by 
2026 according to a new study by Polaris Market Research.
Increasing pool of patients and greater mortality rates through cancer worldwide have 
encourage the need for cancer immunotherapy. Cancer is the second leading cause 
mortalities in 2019, with continuous rise in the number of cancer patient across the globe, 
as per the report published by WHO. Furthermore, it is estimated that 1 out of 6 deaths 
occurs due to cancer every year across the globe. As per WHO, nearly one-third of the 
mortalities from cancer are due to 5 leading behavioral and dietary risk, which includes low 
fruit and vegetable intake, high body mass index, lack of physical activity, alcohol 
consumption, and tobacco use. Tobacco is one of the leading factors for the rise in the 
prevalence of cancer and mortalities that accounted to nearly 22% of the global population. 
Rising number of cancer patients is the major factor for the growth of global diagnostic 
biomarker market.
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 2
Cancer Immunotherapy Market Scope
By Type By  Application By End-user By Region Report Attributes
 Monoclonal Antibodies  Lung Cancer  Hospitals  North America  Historic year: 2015-2018
 Cancer Vaccines,  Breast Cancer  Clinics  Europe  Base year: 2019
 Check Point Inhibitors &  Colorectal Cancer  Others  Asia Pacific  Forecast Year: 2020-2026
Immunomodulators  Melanoma  Latin America Middle  Revenue (USD Billion)
 Prostate Cancer East & Africa 
 Head & Neck Cancer
Request for sample
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 3
 Cancer Immunotherapy Market Estimate & Forecast to 2026
Moreover, emerging market such as Asia-pacific has substantial opportunity in the market. 
The factors that will be favorable to the growth of the market in the emerging market 
includes increasing government expenditures on healthcare in Asian countries, and the 
presence of huge population suffering with colorectal cancer and other cancer types. The 
cancer cases in Asia are increasing at a rapid rate. According to the WHO, there were an 
estimated 4 million mortalities from cancer in Asia in 2016. Cancer is the leading cause of 
mortality in China as there are 4 million new cancer patients diagnosed every year.  
The same condition is in South Korea, as there are more than 200,000 new cancer cases a 
year. The increase in cancer cases in Asia can be accounted to the lifestyle and 
demographic changes. According WHO The incidences of colorectal cancer India were 
estimated about 1,85,000 in 2017. Japan accounted 1,49,000 cases in the 2017 according to 
national cancer institute. The average annual increase in government healthcare spending 
in the US is 4.5% and less than 1.5% in the European Union. However, Asian countries 
increase in healthcare expenditure is more than 6%, which is higher than the developed 
nations. Japan has the highest growth in the healthcare. Thus, creating significant 
opportunity in the market. 
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 4
                                                                    
                                                                         Browse Complete Report
                                                                      
Cancer Immunotherapy Market  Size
Request for TOC
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 5
Cancer Immunotherapy Market  Study – Engagement Options
Buy Now – Click Here!
Buy now & have immediate access to premium insights
Purchase Report Sections – Click Here!
Regional analysis
Segmentation analysis
 Industry outlook
Competitive landscape
Speak To Analyst – Click Here!
Get your doubts clear
Schedule a call with our analyst before making any decision
Request For Sample Pages – Click Here!
Get free sample pages 
Understand report structure
Unmask data for validation
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 6
About Us
Polaris Market Research is a global market research and consulting company. The company 
specializes in providing exceptional market intelligence and in-depth business research services 
for our clientele spread across different enterprises. We at Polaris are obliged to e present across 
the industries of healthcare, technology, semi-conductors and chemicals among various other 
industries present around the world. 
We strive to provide our customers with updated information on innovative technologies, high 
growth markets, emerging business environments and latest business-centric applications, 
thereby helping them always to make informed decisions and leverage new opportunities. Adept 
with a highly competent, experienced and extremely qualified team of experts comprising SMEs, 
analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our 
customers.
 
Web: www.polarismarketresearch.com
Official Blog: http://polarismarketresearch.blogspot.com
Copyright © Polaris Market Research & Consulting LLP 2018. All Rights Reserved 7
Thank You!
Contact Us :
Polaris Market Research
30 Wall Street
8th Floor, 
New York City, NY 10005,
United States
E mail Id: [email protected]
Phone: +1-646-568-9980